Welcome to LookChem.com Sign In|Join Free

CAS

  • or

50461-51-3

Post Buying Request

50461-51-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50461-51-3 Usage

Chemical structure

Tetrahydrobipyridine compound

Pharmacological activity

Potential as a therapeutic agent for various conditions

Central nervous system

Acts as a depressant

Potential therapeutic applications

Addiction, anxiety, and pain management

Mechanism of action

Interacts with the brain's GABA receptors

Effects

Sedative and anxiolytic (anxiety-reducing) properties

Neurological disorders

Studied for potential treatment of Parkinson's disease and epilepsy

Ongoing research

Continued investigation into its therapeutic applications and potential benefits
These properties and contents are based on the information provided and highlight the compound's potential uses and areas of study.

Check Digit Verification of cas no

The CAS Registry Mumber 50461-51-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,4,6 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 50461-51:
(7*5)+(6*0)+(5*4)+(4*6)+(3*1)+(2*5)+(1*1)=93
93 % 10 = 3
So 50461-51-3 is a valid CAS Registry Number.

50461-51-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(1,2,3,6-tetrahydropyridin-4-yl)pyridine

1.2 Other means of identification

Product number -
Other names 2,4'-Bipyridine,1',2',3',6'-tetrahydro

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50461-51-3 SDS

50461-51-3Relevant articles and documents

Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists

Kim, Eunkyung,Park, Chan Sun,Han, Taedong,Bae, Myung-Ho,Chong, Wonee,Lee, Choong Hyun,Shin, Young Ah,Ahn, Byung-Nak,Kim, Mi Kyung,Shin, Chang Yell,Son, Moon Ho,Kim, Jin Kwan,Moon, Ho Sang,Shim, Hyun Joo,Kim, Eun Jung,Kim, Soon Hoe,Lim, Joong In,Lee, Chun Ho

scheme or table, p. 4993 - 4996 (2009/05/26)

Aryl-tetrahydropyridine derivatives were prepared and their PPARα/γ dual agonistic activities were evaluated. Among them, compound (S)-5b was identified as a potent PPARα/γ dual agonist with an EC50 of 1.73 and 0.64 μM in hPPARα and γ, respectively. In diabetic (db/db) mice, compound (S)-5b showed good glucose lowering efficacy and favorable pharmacokinetic properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 50461-51-3